These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2576087)

  • 21. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
    Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
    Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients.
    Mihalik SJ; Moser HW; Watkins PA; Danks DM; Poulos A; Rhead WJ
    Pediatr Res; 1989 May; 25(5):548-52. PubMed ID: 2717271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with peroxisomal disorders indicates heterogeneity of the primary defect.
    Guerroui S; Aubourg P; Chen WW; Hashimoto T; Scotto J
    Biochem Biophys Res Commun; 1989 May; 161(1):242-51. PubMed ID: 2471528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sterol carrier protein X (SCPx) is a peroxisomal branched-chain beta-ketothiolase specifically reacting with 3-oxo-pristanoyl-CoA: a new, unique role for SCPx in branched-chain fatty acid metabolism in peroxisomes.
    Wanders RJ; Denis S; Wouters F; Wirtz KW; Seedorf U
    Biochem Biophys Res Commun; 1997 Jul; 236(3):565-9. PubMed ID: 9245689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisomes of normal morphology but deficient in 3-oxoacyl-CoA thiolase in rhizomelic chondrodysplasia punctata fibroblasts.
    Heikoop JC; Van den Berg M; Strijland A; Weijers PJ; Schutgens RB; Just WW; Wanders RJ; Tager JM
    Biochim Biophys Acta; 1991 Jul; 1097(1):62-70. PubMed ID: 1677591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans.
    Jansen GA; Mihalik SJ; Watkins PA; Moser HW; Jakobs C; Denis S; Wanders RJ
    Biochem Biophys Res Commun; 1996 Dec; 229(1):205-10. PubMed ID: 8954107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of the human peroxisomal branched-chain acyl-CoA oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence for the absence of the protein in Zellweger syndrome.
    Baumgart E; Vanhooren JC; Fransen M; Marynen P; Puype M; Vandekerckhove J; Leunissen JA; Fahimi HD; Mannaerts GP; van Veldhoven PP
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13748-53. PubMed ID: 8943006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of the three peroxisomal beta-oxidation enzymes is synergistically regulated by dexamethasone and fatty acids, and counteracted by insulin in Morris 7800C1 hepatoma cells in culture.
    Sørensen HN; Gautik KM; Bremer J; Spydevold O
    Eur J Biochem; 1992 Sep; 208(3):705-11. PubMed ID: 1356767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical and biochemical studies of fatty acid oxidation in fibroblasts of Zellweger and X-linked adrenoleukodystrophy patients.
    Reubsaet FA; Veerkamp JH; Brückwilder ML; Trijbels JM; Hashimoto T; Monnens LA
    Biochim Biophys Acta; 1991 Jun; 1083(3):305-9. PubMed ID: 2049396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of peroxisomal 3-ketoacyl-coA thiolase from rat liver.
    Miyazawa S; Furuta S; Osumi T; Hashimoto T; Ui N
    J Biochem; 1981 Aug; 90(2):511-9. PubMed ID: 6117552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisomal disorders in children: immunohistochemistry and neuropathology.
    Kamei A; Houdou S; Takashima S; Suzuki Y; Becker LE; Armstrong DL
    J Pediatr; 1993 Apr; 122(4):573-9. PubMed ID: 8463903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisomal bifunctional enzyme deficiency.
    Watkins PA; Chen WW; Harris CJ; Hoefler G; Hoefler S; Blake DC; Balfe A; Kelley RI; Moser AB; Beard ME
    J Clin Invest; 1989 Mar; 83(3):771-7. PubMed ID: 2921319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders.
    Wanders RJ; Denis S; van Berkel E; Wouters F; Wirtz KW; Seedorf U
    J Inherit Metab Dis; 1998 Jun; 21(3):302-5. PubMed ID: 9686381
    [No Abstract]   [Full Text] [Related]  

  • 35. Significance of catalase in peroxisomal fatty acyl-CoA beta-oxidation.
    Hashimoto F; Hayashi H
    Biochim Biophys Acta; 1987 Sep; 921(1):142-50. PubMed ID: 2887206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of peroxisomal fatty acyl-CoA oxidase by antimycin A.
    Vamecq J; Schepers L; Parmentier G; Mannaerts GP
    Biochem J; 1987 Dec; 248(2):603-7. PubMed ID: 3435468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A specific method for determination of peroxisomal beta-oxidation activity in cultured human skin fibroblasts using a specific substrate, C9: a possible application for screening of peroxisomal disorders.
    Suzuki H; Yamada J; Watanabe T; Suga T
    Clin Chim Acta; 1992 Apr; 207(1-2):19-29. PubMed ID: 1591864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of peroxisomal lipid beta-oxidation enzymes in guinea pig liver peroxisomes by immunoblotting and immunocytochemistry.
    Yamamoto K; Völkl A; Fahimi HD
    J Histochem Cytochem; 1992 Dec; 40(12):1909-18. PubMed ID: 1360481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal diagnosis of Zellweger syndrome by measurement of very long chain fatty acid (C26:0) beta-oxidation in cultured chorionic villous fibroblasts: implications for early diagnosis of other peroxisomal disorders.
    Wanders RJ; van Wijland MJ; van Roermund CW; Schutgens RB; van den Bosch H; Tager JM; Nijenhuis A; Tromp A
    Clin Chim Acta; 1987 Jun; 165(2-3):303-10. PubMed ID: 3652452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical analysis of the peroxisomal beta-oxidation enzymes in rat and human heart and skeletal muscle and in skeletal muscle of Zellweger patients.
    Reubsaet FA; Brückwilder ML; Veerkamp JH; Trijbels JM; Hashimoto T; Monnens LA
    Biochem Med Metab Biol; 1991 Apr; 45(2):197-203. PubMed ID: 1883627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.